Ritholtz Wealth Management’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$725K Buy
6,570
+971
+17% +$93.8K 0.01% 748
2026
Q2
$438K Sell
5,599
-2,978
-35% -$203K 0.01% 905
2026
Q1
$554K Sell
8,577
-2,695
-24% -$190K 0.01% 753
2025
Q4
$759K Buy
11,272
+2,525
+29% +$170K 0.01% 591
2025
Q3
$642K Buy
+8,747
New +$581K 0.01% 610

Other funds holding HALO

Ritholtz Wealth Management's HALO Position: Q3 2026 in Review

Ritholtz Wealth Management increased its Halozyme (HALO) stake by 17% in Q3 2026, buying an estimated $93.8K and bringing the position to 6,570 shares worth $725K. The position accounts for 0.01% of the portfolio, ranked #748.

Ritholtz Wealth Management first reported a position in HALO in Q3 2025 and has held it in 5 quarters since. The position peaked at $759K in Q4 2025. 768 funds tracked by Wall St. Rank hold HALO as of Q3 2026.

  • Ritholtz Wealth Management held 6,570 shares of Halozyme worth $725K as of Q3 2026.
  • Ritholtz Wealth Management bought 971 Halozyme shares in Q3 2026, an estimated $93.8K.
  • Halozyme made up 0.01% of Ritholtz Wealth Management's portfolio in Q3 2026, its #748 holding.
  • Ritholtz Wealth Management first reported a position in Halozyme in Q3 2025 and has held it in 5 quarters since.
  • Ritholtz Wealth Management's Halozyme position peaked at $759K in Q4 2025.
  • 768 funds tracked by Wall St. Rank held Halozyme as of Q3 2026.

Based on Ritholtz Wealth Management's 13F filing for Q3 2026, filed 5 Nov 2026.